You are here
AMP Partners
On this page
AMP is a multi-sector partnership. AMP partners share expertise and resources to enable the best-informed contributions to science from all participants.
Government
- FDA
- NIH
- European Medicines Agency
Industry
- AbbVie
- Amgen
- Bayer US
- Biogen Inc.
- Boehringer Ingelheim
- Bristol Myers Squibb
- Celgene Corporation
- Cytokinetics, Inc.
- Danaher Corporation
- Eisai Inc.
- Eli Lilly and Company
- Elipida
- EMD Serono
- Forge
- Gates Ventures
- GlaxoSmithKline plc
- Ionis Pharmaceuticals, Inc.
- Janssen Research & Development, LLC
- Merck Sharp & Dohme Corp.
- Mitsubishi Tanabe Pharma America, Inc.
- Novo Nordisk
- ±·´Ç±¹²¹°ù³Ù¾±²õÌý´¡³Ò
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Ovid Therapeutics Inc.
- Pfizer Inc.
- QurAlis
- REGENXBIO Inc.
- Sanofi
- Spark Therapeutics
- Takeda Pharmaceutical Company Limited
- Taysha Gene Therapies
- Thermo Fisher Scientific
- UCB
- Ultragenyx Pharmaceutical
- Ultromics
- Verily
- Vistera
Non-Profit
-
Alliance for Regenerative Medicine (ARM)
-
Aligning Science Across Parkinson’s (ASAP) Initiative
-
ALS Association
-
ALS Therapy Developement Institute
-
ALS United
- Alzheimer’s Association®
-
American Heart Association®
-
American Diabetes Association
-
American Psychiatric Association Foundation
-
American Society of Gene & Cell Therapy
-
American Society of Echocardiography (ASE)
-
Answer ALS
-
Autoimmune Foundation
-
California Institute for Regenerative Medicine
-
Critical Path Institute
-
CureDuchenne
-
Foundation Fighting Blindness
-
Foundation for the NIH
-
Gates Ventures
-
Genetic Alliance
-
GENETHON
-
JDRF International
-
Lupus Foundation of America
-
Lupus Research Alliance
-
Michael J. Fox Foundation for Parkinson’s Research
-
National Alliance on Mental Illness
-
National Organization for Rare Disorders (NORD)
-
National Psoriasis Foundation
-
One Mind
-
PhRMA
-
Rett Syndrome Research Trust
-
Rheumatology Research Foundation
-
RTW Charitable Foundation
-
Sjögren’s Foundation
- Target ALS
-
The Arthritis Foundation, Inc.
-
The Association for Frontotemporal Degeneration
-
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
-
Schizophrenia & Psychosis Action Alliance
-
Wellcome
This page last reviewed on May 28, 2024